PGRN/PAT: The genomic basis for susceptibility to drug-induced long QT syndrome (diLQTS)
|Study ID||Alternative Stable ID||Type|
The goal of this study was to search for genetic variants that could be responsible for modifying the risk of drug-induced long QT syndrome (diLQTS). diLQTS is a relatively common adverse drug event and has been a leading cause for drug relabeling and withdrawal from the market. Our hypothesis, that variants in genes which regulate electrical properties in the heart modify the risk of diLQTS, was tested by sequencing approximately 225 patients of European descent using next-generation targeted captured or whole exome sequencing. Data from cases and controls (1:2) were analyzed to identify both rare and common genetic variation.
|Archive||Link Archive Accession|
Who archives the data?
There are no publications available